SNY - Sanofi Stock Analysis | Stock Taper
Logo

About Sanofi

https://www.sanofi.com

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.

Paul Hudson

CEO

Paul Hudson

Compensation Summary
(Year )

Total Compensation (Unknown At The Moment)
Industry Drug Manufacturers - General
Sector Healthcare
Went public July 1, 2002
Full time employees 82,878

Split Record

Date Type Ratio
2013-09-30 Forward 5:1
2010-11-17 Forward 10:1

ETFs Holding This Stock

Ratings Snapshot

Rating : A-

Discounted Cash Flow 4
Return On Equity 4
Return On Assets 4
Debt To Equity 2
Price To Earnings 3
Price To Book 4
Overall Score 4

Most Recent Analyst Grades

Grade Summary

Buy 1
Overweight 1
Neutral 2

Showing Top 4 of 4

Price Target

Target High $64
Target Low $48.07
Target Median $58
Target Consensus $57.02

Institutional Ownership

Summary

% Of Shares Owned 7.06%
Total Number Of Holders 971

Showing Top 3 of 971